Alphabet's Isomorphic Labs Raises $5 Billion in Sequoia-Led Round

Isomorphic Labs, the drug discovery company associated with Alphabet, has raised $5 billion in a funding round led by Sequoia. The company's chief executive, Demis Hassabis, said the new capital will be used to speed up the firm's progress toward clinical trials. The round positions Isomorphic to advance its AI-driven approach to developing new medicines. Further details on the timing and specific investors beyond the lead were not provided in the source material.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in